Join
Live feed
·
NEWSReleasevia Quantisnow
Ocuphire Pharma Inc. logo

Ocuphire Pharma Participates In ARVO SIG Panel And ASRS 42nd Annual Scientific Meeting To Highlight APX3330 For Diabetic Retinopathy

ByQuantisnow·Wall Street's wire, on your screen.
OCUP· Ocuphire Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCUP (Ocuphire Pharma Inc.) and more on Quantisnow.